Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus

To investigate the safety of NST-001, delivered directly to the inner ear.

  1. Tinnitus Talk
    This research study involves an experimental drug (NST_001) and a delivery system. The main purpose of this research study is to investigate the safety of NST-001, delivered directly to the inner ear for the treatment of tinnitus.


    Estimated Enrollment: 24
    Study Start Date: January 2009
    Estimated Study Completion Date: December 2011
    Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
If you have ringing ears then you've come to the right place. We are a friendly tinnitus support board, dedicated to helping you discuss and understand what tinnitus treatments may work for you.